IDEAYA Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
IDEAYA Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q2 2024.
  • IDEAYA Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$52.8M, a 89% decline year-over-year.
  • IDEAYA Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$154M, a 107% decline year-over-year.
  • IDEAYA Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$113M, a 92.6% decline from 2022.
  • IDEAYA Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$58.7M, a 17.9% decline from 2021.
  • IDEAYA Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$49.8M, a 44.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$154M -$52.8M -$24.8M -89% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$129M -$39.6M -$15.9M -67.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$113M -$34M -$9.75M -40.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 -$103M -$27.4M -$29.1M -1799% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$74.2M -$27.9M -$5.87M -26.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$68.3M -$23.6M -$9.63M -68.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$58.7M -$24.2M -$5.99M -32.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$52.7M $1.62M +$13.2M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$65.9M -$22.1M -$11.1M -101% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$54.8M -$14M -$4.99M -55.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$49.8M -$18.2M -$13.1M -255% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 -$36.7M -$11.6M -$6.66M -135% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$30M -$10.9M +$1.44M +11.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$31.5M -$9.02M +$3.02M +25.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$34.5M -$5.14M +$5.65M +52.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 -$40.1M -$4.93M +$6.04M +55.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$46.2M -$12.4M -$1.74M -16.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$44.4M -$12M -$2.47M -25.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$42M -$10.8M -$2.22M -25.9% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-24
Q3 2019 -$39.8M -$11M +$2.08M +16% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$41.8M -$10.7M -$3.66M -52.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$38.2M -$9.57M -$3.83M -66.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$34.3M -$8.56M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 -$13.1M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-24
Q2 2018 -$7M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-24
Q1 2018 -$5.74M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.